Margaret Lake Diamonds Closes First Tranche of Flow-Through and Non-Flow Through Private Placement for Gross Proceeds of $495,500
Bonterra Achieves up to 99.4% Gold Recoveries from Preliminary Metallurgical Studies, Including up to 76.1% from the Gravity Circuit
Isodiol International Inc. Announces Major International Expansion and Innovation Due to Global Demand
TechXtend Education Solutions Partner with RoboKind to Bring Social-Emotional Learning to Students with Autism
Medtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere Embolization Spheres
Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series Products That Provide Automated, Closed System Cellular Processing
VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients
Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi’s European generics business
CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
Maple Leaf Green World Inc. Receives Final Approval to List on the NEO Exchange and Delist Common Shares from the TSXV
Enforcer Announces Completion of the Phase 1 Drilling Program on the Mop-II Gold-Copper Deposit, Roger Project, Québec
MGX Minerals Files Technical Report for Driftwood Creek Magnesium Preliminary Economic Assessment; Pre-Tax NPV of C$529.8 Million
Ely Gold CEO: We Own a Royalty and Option Portfolio of 42 Development Properties Being Explored by Third Parties
Innovation Pharmaceuticals Data from Phase 2 Brilacidin Oral Mucositis (OM) Trial in Head and Neck Cancer Show Notable Reductions in Median Duration of Severe OM
Apellis Pharmaceuticals Provides Update on Phase 1b Open Label Study of APL-2 in PNH Patients Not Previously Treated with Eculizumab
New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccine’s Proprietary Delivery Platform
Aptevo Therapeutics’ Bispecific Antibody APVO436 Shows Robust T-Cell Activation With Minimal Cytokine Release
US Cobalt Drills More High Grade Cobalt, Demonstrates Further Deposit Continuity and Discovers Footwall Zone
VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
BeiGene Presents Clinical Data on Pamiparib in Chinese Patients with Ovarian Cancers or Triple-Negative Breast Cancer
Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018
Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting
BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Relapsed or Refractory Mature T-and NK-Cell Lymphomas
Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation to Expand the Clinical Research on IMO-2125
Humanigen Signs Agreement With MD Anderson Cancer Center to Begin Research Investigating Lenzilumab as CAR-T Support
West Corporation Closes Landmark Acquisition of Nasdaq’s Public Relations and Digital Media Businesses